DoseSpot Acquires TreatRx ePrescribing Platform from Bravado Health

March 28, 2023

DoseSpot, a Dedham, Massachusetts-based ePrescribing SaaS provider, has acquired the TreatRx ePrescribing segment from Bravado Health to expand its clinical prescribing capabilities and integrate TreatRx’s technology into its platform. The move follows a prior strategic investment in DoseSpot led by PSG and is intended to broaden DoseSpot’s solution set for healthcare providers while ensuring a seamless transition for TreatRx customers.

Buyers
DoseSpot, PSG
Targets
TreatRx (Bravado Health ePrescribing Platform)
Sellers
Bravado Health
Location
United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.